Geron to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its fourth quarter and full-year 2024 financial results and business highlights...